Search results for "Atrial natriuretic factor"

showing 10 items of 39 documents

The natriuretic system in human and murine submandibular salivary glands in health and disease: insights from head and neck tumour cases

2019

Introduction: The wide distribution of the atrial natriuretic peptide was paralleled by a similar presence of its receptors, an indication of the wide range of their biological effects beyond the control of the homeostatic process. This study depicts through immunohistochemical and molecular techniques the distribution and modulation of atrial natriuretic peptide and its receptors in human and murine salivary glands. It also highlights some clinical implications of ANP dysregulation. Methods: Human SMG’s tissue samples were biopsied from normal (3), people with benign (2) or with malignant tumors (8). In addition, biopsies were taken from normal mice (10). They were processed by standard me…

Atrial natriuretic factorAtrial natriuretic peptidemarker for oral carcinomaSubmandibular gland tumor
researchProduct

The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population

2013

OBJECTIVE We hypothesized that the minor allele of the atrial natriuretic peptide (ANP) genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a general Mediterranean population. RESEARCH DESIGN AND METHODS We genotyped a random sample of the residents of Ventimiglia di Sicilia, Sicily, for rs5068. RESULTS Genotype frequencies of rs5068 are AA, 93.5%; AG, 6.4%; and GG, 0.1%. All subsequent analyses are AA versus AG+GG. After adjusting for age and sex, the minor G allele is associated with lower BMI (estimate [SE]: −1.7 kg/m2 [0.8], P = 0.04). In the AG+GG group, males with HDL cholesterol levels <40 mg/dL are less frequent (P = 0.05) and obesity tends to …

AdultMalegenetic variantCardiovascular and Metabolic Riskmedicine.medical_specialtySettore MED/09 - Medicina InternaGenotypeEndocrinology Diabetes and MetabolismPopulationBlood PressureGene Frequencycardiometabolic phenotypeAtrial natriuretic peptideInternal medicineNatriuretic Peptide Brainatrial natriuretic peptideInternal MedicinemedicineHumansAlleleeducationAllele frequencyAgedOriginal ResearchAdvanced and Specialized Nursingeducation.field_of_studybusiness.industryOdds ratioMiddle Agedmedicine.diseaseGenotype frequencyMinor allele frequencyPhenotypeEndocrinologyFemaleMetabolic syndromebusinessAtrial Natriuretic FactorDiabetes Care
researchProduct

Atrial Natriuretic Peptide presence in parotid gland of human fetus at 13th week of development and in adult man

2013

Our immunohistochemical study shows that atrial natriuretic peptide (ANP) is present in both human fetal and adult parotid gland. In the fetuses ANP is localized in cell clusters, while in adult parotid gland, the ANP is seen only in the wall of intra- and extralobular ducts. The results suggest that ANP might play a role in the differentiation of the parotid gland similarly as in brain and that during fetal growth ANP may play a role in the regulating the secretion of primitive salivary fluid, even if acini are still not developed. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 1, 55-58)

Settore BIO/17 - IstologiaAdultMalemedicine.medical_specialtyHistologyGestational AgePeptide hormonePathology and Forensic MedicineFetusstomatognathic systemAtrial natriuretic peptideANPhuman parotid glandontogenyInternal medicineinglesemedicineAcinar cellHumansParotid GlandSecretionFetusSettore BIO/16 - Anatomia Umanabusiness.industryGeneral MedicineParotid glandmedicine.anatomical_structureEndocrinologyHuman fetalcardiovascular systemImmunohistochemistrybusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologyFolia Histochemica et Cytobiologica
researchProduct

Mechanisms underlying the diabetes-induced hyporeactivity of the rabbit carotid artery to atrial natriuretic peptide

2010

Abstract Atrial natriuretic peptide (ANP) plays an important role in the pathophysiology of the vascular complications in diabetes. The working hypothesis was that diabetes might modify the vascular actions of ANP in isolated rabbit carotid arteries and the mechanisms involved in these actions. ANP (10 −12 –10 −7  M) induced a relaxation of precontracted carotid arteries, which was lower in diabetic than in control rabbits. In arteries from both groups of animals, endothelium removal increased the ANP-induced relaxation. Isatin inhibited the relaxation to ANP both in arteries with and without endothelium. Carotid arteries from diabetic rabbits showed a decreased natriuretic peptide receptor…

Malemedicine.medical_specialtyEndotheliummedicine.drug_classThromboxaneDown-RegulationProstacyclinVasodilationDiabetes Mellitus ExperimentalRandom AllocationAtrial natriuretic peptideDiabetes mellitusInternal medicinemedicineNatriuretic peptideAnimalsReceptorPharmacologybusiness.industrymedicine.diseaseVasodilationCarotid Arteriesmedicine.anatomical_structureEndocrinologycardiovascular systemRabbitsbusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugPharmacological Research
researchProduct

Localization of the atrial natriuretic factor in the human inferior turbinates. An immunohistochemical study

2003

In man, the architecture of the turbinates is able to modify some of the physiochemical characteristics of the air inhaled. These modifications depend on the nervous system and on the action of neurotransmitters such as vasoactive intestinal peptide. Substance P, calcitonin gene-related peptide and other neuropeptides. As atrial natriuretic factor has been detected in the trachea and lung, the present immunohistochemical study was carried out to establish the presence and localisation of the atrial natriuretic factor on the inferior turbinates of the human being. The findings show atrial natriuretic factor to be present in the serous epithelial cells and in some cells of the tonaca propria …

Nasal MucosaHumansEpithelial CellsAtrial natriuretic factorinferior turbinatesTurbinatesImmunohistochemistryAtrial Natriuretic Factor
researchProduct

Plasma levels of atrial natriuretic peptide and hemodynamic function in cardiac disease.

1993

Plasma concentrations of atrial natriuretic peptide were measured in eight patients with cardiac disease but normal resting right atrial pressure, during cardiac catheterization. No patient had clinical evidence of overt heart failure. An increase in peptide concentrations was observed between the aorta or the peripheral vein and the pulmonary artery. A linear relation was found between peripheral vein and pulmonary artery peptide concentration. Mean pulmonary artery and capillary wedge pressure also correlated with the peptide levels. No correlation was observed between mean right atrial pressure and peptide concentration. These findings demonstrate that atrial natriuretic peptide release,…

AdultMalemedicine.medical_specialtyHeart Diseasesmedicine.medical_treatmentRadioimmunoassayRenin-Angiotensin SystemCatecholaminesAtrial natriuretic peptideInternal medicinemedicine.arterymedicineHumansPulmonary wedge pressureCardiac catheterizationAgedAged 80 and overAortabusiness.industryLow pressure receptor zonesCentral venous pressureHemodynamicsMiddle Agedmedicine.diseaseArginine VasopressinEndocrinologyHeart failurePulmonary arterycardiovascular systemCardiologyAtrial Function LeftFemaleCardiology and Cardiovascular MedicinebusinessAtrial Natriuretic FactorInternational journal of cardiology
researchProduct

Presence of Oxytocin, Vasopressin and Atrial Natriuretic Peptide and Their Modification in Rat Hypothalamic Paraventricular Nucleus During Resistance…

2013

Summary Many studies have demonstrated the physiological effects of oxytocin (OT), atrial natriuretic peptide (ANP) and vasopressin (VP) in the homoeostasis of body fluids during physical exercise. However, a little information is available about the related immunohistochemical changes in hypothalamic magnocellular neurosecretory system during and after the training. The aim of the present work was to study the immunohistochemical changes in OT, ANP and VP levels in the hypothalamic paraventricular nucleus during and after resistance exercise protocol. Three groups of Wistar rats were trained by a rung ladder protocol for 15, 30 and 45 days, respectively; a fourth group was left to rest for…

MaleVasopressinmedicine.medical_specialtyVasopressinsPeriod (gene)Physical exerciseOxytocinAtrial natriuretic peptidePhysical Conditioning AnimalInternal medicinemedicineAnimalsRats WistarNeuronsBody fluidGeneral Veterinarybusiness.industryOxytocin vasopressinANPbrainResistance TrainingGeneral MedicineRatsmedicine.anatomical_structureEndocrinologyGene Expression RegulationOxytocinsense organsbusinessNucleusAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistsHomeostasisParaventricular Hypothalamic Nucleusmedicine.drugAnatomia, Histologia, Embryologia
researchProduct

Natriuretic peptide system: physiology and clinical utility

2004

This review discusses the physiology of natriuretic peptides as a group and brain natriuretic peptide (BNP) in more detail. It will also highlight implications for the use of the natriuretic peptides in the diagnosis and treatment of patients with cardiovascular disease.The heart secretes two major natriuretic peptides: atrial natriuretic peptide (ANP), which is synthesized in the atrial myocardium, and BNP, which is synthesized in the ventricular myocardium. Both ANP and BNP are released in response to atrial and ventricular stretch, respectively, and will cause balanced vasodilation, natriuresis, and inhibition of the sympathetic nervous system and the renin-angiotensin-aldosterone axis. …

business.industrymedicine.drug_classMolecular Sequence DataPhysiologyPrognosisCritical Care and Intensive Care MedicineBrain natriuretic peptideNPR2Cardiovascular DiseasesNatriuretic Peptide BrainNatriuretic peptideHumansMedicineAmino Acid SequenceNatriuretic PeptidesbusinessPeptide sequenceAtrial Natriuretic FactorBiomarkersCurrent Opinion in Critical Care
researchProduct

Presence of atrial natriuretic factor in normal and hyperplastic human prostate and its relationship with oxytocin localisation

2003

In this work, we showed the presence of atrial natriuretic factor (ANF) in human prostate and compared its localisation in normal and hyperplastic conditions. ANF was localised in epithelial and stromal cells, being increased in hyperplasia, mainly in the stromal component. Moreover, we compared ANF and oxytocin positivity in the same glands, focusing on the possible relationship between the paracrine effects of these two hormones.

MaleProstatic Diseasesmedicine.medical_specialtyHistologyStromal cellProstatic HyperplasiaBiophysicsProstatic hyperplasia pathogenesiOxytocinHuman prostateImmunoenzyme TechniquesParacrine signallingProstatic fluidInternal medicineotorhinolaryngologic diseasesmedicineHumanslcsh:QH301-705.5ANF; Oxytocin; Prostatic fluid; Prostatic hyperplasia pathogenesis; Cell Biology; Anatomy; Animal Science and Zoology; Developmental Biologybusiness.industryProstateCell BiologyHyperplasiamusculoskeletal systemmedicine.diseaseEndocrinologylcsh:Biology (General)OxytocinANFembryonic structurescardiovascular systemAnimal Science and ZoologyAnatomyStromal CellsbusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistsDevelopmental Biologymedicine.drugHormoneEuropean Journal of Histochemistry
researchProduct

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treate…

2021

Background We assessed the impact of preprocedural plasma levels of MRproANP (midregional N‐terminal pro–atrial natriuretic peptide) and sST2 (soluble suppression of tumorigenicity 2) on recurrence of atrial fibrillation (AF) at 1 year after catheter ablation of AF. Methods and Results This was a prospective, multicenter, observational study including patients undergoing catheter ablation of AF. MRproANP and sST2 were measured in a peripheral venous blood preprocedure, and MRproANP was assessed in the right and left atrial blood during ablation. The primary end point was recurrent AF between 3 and 12 months postablation, defined as a documented (>30 seconds) episode of AF, flutter, or a…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classmedicine.medical_treatmentBiorhythmCatheter ablation030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineHeart RatePredictive Value of TestsRecurrenceRisk FactorsInternal medicinecatheter ablationAtrial FibrillationmedicineNatriuretic peptideHumansIn patientArrhythmia and Electrophysiology030212 general & internal medicineHeart AtriaProspective StudiesOriginal ResearchAgedsST2business.industryMRproANPbiomarkersAtrial fibrillationPlasma levelsMiddle Agedmedicine.diseaseInterleukin-1 Receptor-Like 1 ProteinUp-RegulationHeart RhythmTreatment OutcomePro atrial natriuretic peptideCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessCatheter Ablation and Implantable Cardioverter-DefibrillatorAtrial Natriuretic FactorJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
researchProduct